Saponine

Saponine is a Belgian biotechnology company specializing in the sustainable production and purification of high-quality saponins for use as vaccine adjuvants. A spin-off from the University of Mons and the University of Liège, the company utilizes proprietary technology to produce pharmaceutical-grade QS-21, a critical immune-boosting compound. Their innovative approach addresses the environmental and supply chain limitations associated with traditional extraction from the Chilean Soapbark tree. Saponine's products are designed to enhance the efficacy of vaccines against infectious diseases and various forms of cancer. By providing a scalable and reliable source of these essential molecules, the company supports the development of next-generation immunotherapies and global health initiatives.